Skip to main content
. 2016 Jan 18;37(3):322–333. doi: 10.1038/aps.2015.105

Figure 4.

Figure 4

Effect of Y-QA31 on methamphetamine- or MK-801-induced hyperlocomotion in mice. (A) Effects of Y-QA31 alone on spontaneous locomotion. (B) Effects of haloperidol alone on spontaneous locomotion. (C) Inhibitory effect of Y-QA31 on methamphetamine-induced hyperlocomotion. (D) Inhibitory effect of haloperidol on methamphetamine-induced hyperlocomotion. (E) Inhibitory effect of Y-QA31 on MK-801-induced hyperlocomotion. n=10–15. cP<0.01 vs the control; eP<0.05, fP<0.01 vs methamphetamine treated group or MK-801 treated group; one-way ANOVA followed by Newman-Keuls test.